Clinical Trial Update: Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion [Phase 4]

View source ↗

Summary

Phase 4 trial comparing famotidine with pantoprazole for preventing recurrent aspirin-induced peptic ulcers/erosions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Famotidine (famotidine)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: Ruttonjee Hospital | Conditions: Peptic Ulcer/Erosions | Phase 4 | Status: COMPLETED